Delirium in elderly hospitalised patients: Protective effects of chronic rivastigmine usage

International Journal of Geriatric Psychiatry

Volumn 19, Issue 7, 2004, Pages 641-644

  Dautzenberg, Paul L J ^a   Mulder, Leonie J ^a   Olde Rikkert, Marcel G M ^b   Wouters, Cees J ^a   Loonen, Anton J M ^c  

^a Dept of Geriat J Bosch Ziekenhuis ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Delta Psychiatrisch Ziekenhuis   (Netherlands)

Author keywords

Delirium; High risk; Prevention; Rivastigmine

Indexed keywords

RIVASTIGMINE;

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DELIRIUM; DEMENTIA; DISEASE DURATION; DRUG EFFICACY; DRUG USE; ELDERLY CARE; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; RETROSPECTIVE STUDY; SOCIAL PSYCHOLOGY; TEACHING HOSPITAL;

AGED; AGED, 80 AND OVER; CARBAMATES; CHOLINESTERASE INHIBITORS; DELIRIUM; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHENYLCARBAMATES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 3242891378     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1138     Document Type: Article

References (18)

1. Brown TM, Boyle MF. 2002. ABC of psychological medicine. Delirium. BMJ 325: 644-647.
2. Dautzenberg PLJ, Wouters CJ, Oudejans I, et al. 2003. Rivastigmine in prevention of delirium in a 65-years old man with Parkinson's disease. Int J Geriatr Psychiatry 18: 555-558.
3. Dautzenberg PLJ, Mulder LJ, Olde Rikkert MGM, et al. 2004. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium. Age Ageing. in Press.
4. Fick DM, Agostini JV, Inouye SK. 2002. Delirium superimposed on dementia: a systematic review. J Am Geriatri Soc 50: 1723-1732.
5. Fischer P. 2001. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor. J Clin Psychopharmacol 21: 118.
6. Flacker JM, Lipsitz LA. 1999. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 54: 239-246.
7. Francis J, Kapoor WN. 1992. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 40: 601-606.
8. Francis PT, Palmer AM, Snape M, Wilcock GK. 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66: 137-147.
9. Han L, McCusker J, Cole M, et al. 2001. Use of medications with anticholinergic effects predicts clinical severity of delirium symptoms in older medical patients. Arch Intern Med 161: 1099-1105.
10. Inouye SK, Rushing JT, Foreman MD, et al. 1998. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 13: 234-242.
11. Kiely DK, Bergmann A, Murphy KM, et al. 2003. Delirium among newly admitted postacute facility patients: prevalence, symptoms and severity. J Gerontology 58A: M441-M445.
12. Liptzin B, Levkoff SE. 1992. An empirical study of delirim. Br J Psychiatry 152: 334-340.
13. van der Mast RC. 1998. Pathophysiology of delirium. J Geriatr Psychiatr Neurol 11: 138-145.
14. Meagher DJ. 2001. Delirium: optimising management. BMJ 322: 144-149.
15. Sipahimalani A, Sime R, Masand P. 1997. Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1: 24-26.
16. Sipahimalani A, Massand P. 1998. Olanzapine in the treatment of delirium. Psychosomatics 39: 422-430.
17. Tune E. 2000. Serum anticholinergic activity levels and delirium in the elderly. Seminars in Clinical Neuropsychiatry 5: 149-153.
18. Wengel SP, Roccaforte WH, Burke WJ. 1998. Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 11: 159-161.